Patterns of Fatigue in Rheumatoid Arthritis Patients Who Received Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs

被引：0
|
作者：
Freites Nunez, Dalifer [1 ]
Leon, Leticia [2 ]
Redondo, Marta [3 ]
Vadillo Font, Cristina [1 ]
Lois, Pia [1 ]
Mucientes Ruiz, Arkaitz [1 ]
Rodriguez-Rodriguez, Luis [2 ]
Fernandez Gutierrez, Benjamin [1 ]
Jover Jover, Juan Angel [1 ]
Abasolo Alcazar, Lydia [1 ]
机构：
[1] Hosp Clin San Carlos, Madrid, Spain
[2] Fdn Invest Biomed, Madrid, Spain
[3] Univ Camilo Jose Ceja, Madrid, Spain
来源：
ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1334
引用
收藏
页数：3
相关论文
共 50 条
  • [31] THE LONG-TERM IMPACT OF FATIGUE ON DISEASE ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH BIOLOGICAL DISEASE-MODIFYING ANTIRHEUMATIC DRUGS
    Oliveira, D. Santos
    Martins, A.
    Martins, F. R.
    Samoes, B.
    Rato, M.
    Pinheiro, F. Oliveira
    Nicolau, R.
    Vaz, C.
    Bernardes, M.
    Costa, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1307 - 1307
  • [32] Is it possible to discontinue glucocorticoids in rheumatoid arthritis with the use of synthetic disease-modifying antirheumatic drugs?
    Iaremenko, O. B.
    Mykytenko, H. M.
    ZAPOROZHYE MEDICAL JOURNAL, 2023, 25 (04) : 309 - 315
  • [33] Adherence to synthetic disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis: Results of the OBSERVAR Study
    Juan Mas, Antonio
    Castaneda, Santos
    Cantero Santamaria, Jose, I
    Baquero, Jose L.
    del Toro Santos, Francisco J.
    de Miguel, Alegre
    Castaneda Sanz, Cayetano
    Castano Sanchez, Santos
    Chamizo Carmona, Manuel
    de Toro Santos, Eugenio
    Garcia Aparicio, Francisco Javier
    Garcia Fernandez, Angel Angel
    Garmendia Sanchez, Maria Edilia
    Hernandez Miguel, Elena
    Hidalgo Calleja, Maria Victoria
    Juan Mas, Cristina
    Martinez Lopez, Antonio
    Martinez Taboada, Juan Antonio
    Monteagudo Saez, Victor
    Naranjo Hernandez, Indalecio
    One Martinez, Antonio
    Perez Galan, Javier
    Rodriguez Escalera, Maria Jose
    Gomez de Salazar, Jose Carlos Rosas
    REUMATOLOGIA CLINICA, 2019, 15 (05): : 264 - 270
  • [34] Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme
    Frisell, Thomas
    Bower, Hannah
    Morin, Matilda
    Baecklund, Eva
    Di Giuseppe, Daniela
    Delcoigne, Benedicte
    Feltelius, Nils
    Forsblad-d'Elia, Helena
    Lindqvist, Elisabet
    Lindstroem, Ulf
    Askling, Johan
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (05) : 601 - 610
  • [35] Disease-modifying antirheumatic drugs and bone mass in rheumatoid arthritis
    Di Munno, O
    Delle Sedie, A
    Rossini, A
    Adamil, S
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2005, 23 (02) : 137 - 144
  • [36] Comparative Risk of Nonvertebral Fractures Among Patients With Rheumatoid Arthritis Treated With Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs
    Pawar, Ajinkya
    Desai, Rishi J.
    He, Mengdong
    Bessette, Lily
    Kim, Seoyoung C.
    ACR OPEN RHEUMATOLOGY, 2021, 3 (08) : 531 - 539
  • [37] Budget Impact of Sequential Treatment with Biologics, Biosimilars, and Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Thai Patients with Rheumatoid Arthritis
    Osiri, Manathip
    Dilokthornsakul, Piyameth
    Chokboonpium, Sasitorn
    Suthipinijtham, Pichaya
    Koolvisoot, Ajchara
    ADVANCES IN THERAPY, 2021, 38 (09) : 4885 - 4899
  • [38] Frailty and Risk of Serious Infections in Patients With Rheumatoid Arthritis Treated With Biologic or Targeted-Synthetic Disease-Modifying Antirheumatic Drugs
    Singh, Namrata
    Gold, Laura S.
    Lee, Jiha
    Wysham, Katherine D.
    Andrews, James S.
    Makris, Una E.
    England, Bryant R.
    George, Michael D.
    Baker, Joshua F.
    Jarvik, Jeffrey
    Heagerty, Patrick J.
    Singh, Siddharth
    ARTHRITIS CARE & RESEARCH, 2024, 76 (05) : 627 - 635
  • [39] Conventional disease-modifying antirheumatic drugs to treat rheumatoid arthritis
    Rath, T.
    Sander, O.
    Rubbert, A.
    DRUG DEVELOPMENT RESEARCH, 2011, 72 (08) : 657 - 663
  • [40] Budget Impact of Sequential Treatment with Biologics, Biosimilars, and Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Thai Patients with Rheumatoid Arthritis
    Manathip Osiri
    Piyameth Dilokthornsakul
    Sasitorn Chokboonpium
    Pichaya Suthipinijtham
    Ajchara Koolvisoot
    Advances in Therapy, 2021, 38 : 4885 - 4899
12345